Role of Epidemiological Data within the Drug Development Lifecycle: A Chronic Migraine Case Study (English)


Share on Facebook Share on Twitter

A public health seminar recorded on October 17, 2011.

Epidemiologists working in the pharmaceutical industry use the principles of descriptive epidemiology in addition to applied concepts and methods to assess the impact, use and effects of drugs in the population and in clinical trial settings. As there is a wide spectrum of data needs and requirements during any drug's lifecycle, a summary, including a real-world example, of the epidemiological data and methods utilized specifically during clinical development phase is timely. This presentation will provide a case study describing how epidemiological data was used to support the registration of onabotulinumtoxinA (BOTOX®, Allergan, Inc., Irvine, CA, USA) for treatment of headaches in adults with chronic migraine.


Author:
Aubrey Manack
Creative Commons License
Role of Epidemiological Data within the Drug Development Lifecycle: A Chronic Migraine Case Study by Aubrey Manack is licensed under a Creative Commons Attribution-ShareAlike Unported 3.0 License
Provide a Testimonial